These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38060600)

  • 21. Digital Transformation on Enterprise Green Innovation: Effect and Transmission Mechanism.
    Feng H; Wang F; Song G; Liu L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative elicitation process for sustainable manufacturing: A novel evolution model of green technology innovation path selection of manufacturing enterprises under environmental regulation.
    Wang M; Yin S; Lian S
    PLoS One; 2022; 17(6):e0266169. PubMed ID: 35687585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of enterprise financialization on green innovation: evidence from Chinese A-share non-financial listed enterprises.
    Li W; Chen L; He S
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):56802-56817. PubMed ID: 36929262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whether Green Finance Improves Green Innovation of Listed Companies-Evidence from China.
    Dong Z; Xu H; Zhang Z; Lyu Y; Lu Y; Duan H
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equity Structure, Strategic Investment Psychology, and Performance in China's Green Economy Context.
    Guo LX; Lin KL; Zhang LT; Liu CF
    Front Psychol; 2021; 12():707582. PubMed ID: 34512465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corporate Digital Transformation and Green Innovation: A Quasi-Nature Experiment from Integration of Informatization and Industrialization in China.
    Zhang Q; Yang M; Lv S
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Governance, financial development and China's outward foreign direct investment.
    Gao C; Wen Y; Yang D
    PLoS One; 2022; 17(6):e0270581. PubMed ID: 35771853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro-perspective of listed companies in China: Digital development promotes the green transformation of the manufacturing industry.
    Wang H; Wu L; Peng G; Du H
    PLoS One; 2023; 18(10):e0293474. PubMed ID: 37883494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How does venture capital cross-border syndication spur corporate innovation? Evidence from China.
    Hao H; Guo L; Dong J
    Front Psychol; 2022; 13():921168. PubMed ID: 35936306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of emission trading system on corporate innovation and productivity-empirical evidence from China's SO
    Tang HL; Liu JM; Mao J; Wu JG
    Environ Sci Pollut Res Int; 2020 Jun; 27(17):21604-21620. PubMed ID: 32279261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supply chain concentration and enterprise financialization: Evidence from listed companies in China's manufacturing industry.
    He H; Zuo Z
    PLoS One; 2023; 18(5):e0285308. PubMed ID: 37163518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can fund shareholding inhibit insufficient R&D input?--Empirical evidence from Chinese listed companies.
    Li X; Liu G
    PLoS One; 2021; 16(3):e0248674. PubMed ID: 33765071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research on wind power industrial policies' functional mechanism to the quality of enterprise innovation.
    Wang X; Tao Z; Pan G; Zou H; Xie Y; Li X
    Environ Sci Pollut Res Int; 2023 Mar; 30(12):34350-34362. PubMed ID: 36509957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incentive effect of tax preferences towards the technological innovation of enterprises--Based on China's GEM listed companies.
    Ding L; Wu Y; Long J
    PLoS One; 2023; 18(4):e0282692. PubMed ID: 37058543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tax Incentives, Tax Enforcement, and Enterprise R&D Investment: Evidence From Chinese A-Share Listed.
    Sun Y
    Front Psychol; 2022; 13():953313. PubMed ID: 35874375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of technological innovation on corporate leverage in China: The moderating role of policy incentives and market competition.
    Ren L; Liu D; Xiong D
    Front Psychol; 2022; 13():1068375. PubMed ID: 36533031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Executive poverty experience and innovation performance: A study of moderating effects and influencing mechanism.
    Jia X; Wang T; Chen C
    Front Psychol; 2022; 13():946167. PubMed ID: 35978777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Technological Innovation Affect China's Pharmaceutical Smart Manufacturing Industrial Upgrading.
    Wang S; Chen Y
    J Healthc Eng; 2021; 2021():3342153. PubMed ID: 34868514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Threshold effects of energy consumption, technological innovation, and supply chain management on enterprise performance in China's manufacturing industry.
    Liu H; Fan L; Shao Z
    J Environ Manage; 2021 Dec; 300():113687. PubMed ID: 34530370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.